Reckitt Sues To Block Par's Generic Suboxone
According to Reckitt, Par’s abbreviated new drug application for a sublingual film, designed with drug delivery company IntelGenX Technologies Corp. and manufactured by LTS Lohmann Therapy Systems Corp., infringes two of the company’s patents for Suboxone — U.S. Patent Numbers 8,475,832 and 8,017,150.
The complaint states that Reckitt received a letter from the defendants on...
Already a subscriber? Click here to login